AbbVie: AbbVie lifts guidance as Q1 results top expectations
Abbvie Inc (NYSE:ABBV) shares moved higher after it reported strong results for the first quarter of 2025 and raised its full-year profit guidance. The...
Read full article »
AbbVie is an Illinois-based biopharmaceutical company that develops and markets medicinal drugs for the treatment of neurodegenerative diseases and cancer.
Read more